The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 0
  • Not found in our database.
parent relation
Company in focus

CORREVIO PHARMA CORP


Related profiles found in government register
  • CORREVIO PHARMA CORP
    S
    Registered number 451118-2
    595 Burrard Street, Suite 2600, V7x 1l3, Vancouver, British Columbia, Canada
    Corporation (Canada) in Registrar Of Companies, British Columbia, British Columbia
    CIF 1
  • CARDIOME PHARMA CORP.
    S
    Registered number 451118-2
    1441, Creekside Drive, 6th Floor, Vancouver, British Columbia, V6j 4s7, Canada
    Corporate in British Columbia, Canada, Canada
    CIF 2
child relation
Offspring entities and appointments
Active 0
  • Not found in our database.
Ceased 2
  • 1
    Dashwood House, 69 Old Broad Street, London, United Kingdom
    Dissolved Corporate (3 parents)
    Person with significant control
    2016-04-06 ~ 2020-05-27
    CIF 1 - Ownership of shares – 75% or more OE
    CIF 1 - Ownership of voting rights - 75% or more OE
  • 2
    IROKO CARDIO (UK) LTD. - 2013-01-15
    Dashwood House, 69 Old Broad Street, London, United Kingdom
    Active Corporate (3 parents)
    Equity (Company account)
    -276,848 GBP2023-12-31
    Person with significant control
    2016-04-06 ~ 2018-05-15
    CIF 2 - Ownership of shares – 75% or more OE
    CIF 2 - Ownership of voting rights - 75% or more OE
© 2022-2025 Polylogarithmic Technology Ltd. All rights reserved.
Contains public sector information retrieved at 24 April 2025 and licensed under the Open Government Licence v3.0.